Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  VEGFR2-targeted contrast agent BR55
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer
Status: Active
Phase: Phase II, Phase I
Type: Diagnostic
Age: 50 to 70
Trial IDs: BR55-105, NCI-2014-02146, NCT02142608
Start Over